Just been diagnosed with prostrate cancer

Posted , 19 users are following.

I am 50 yr old reasonably fit and healthy or at least I thought I was.

My blood test revealed PSA level @ 6.2 which later reduced to 5.8 on my second test , I was sent for a biopsy where the doc told me my prostrate felt enlarged but didn't feel abnormal , unfortunately my results later revealed I have localised prostrate cancer . When the doctor revealed the news yesterday I was in total shock but now realise I am one of the lucky ones as my cancer appears to be none aggressive type, only one of the twelve biopsy samples revealed a small volume of cancer with a Gleason score of 6 which apparently is low.

My worry now is to decide to what to do next regarding treatment.

Do I sit and watch and wait or would anyone out there with a similar story advise otherwise., I am thinking about Prostate Seed Brachytherapy treatment but don't know a lot about the risks after or what the success rate is. At present, besides going to the loo more often my life hasn't been too affected.

Can anyone advise what to do

I have a choice to watch and wait or have radiotherapy ,, my dilemma is what if it spreads . Advice would be greatly appreciated

Yours worried S,,

0 likes, 129 replies

129 Replies

Prev Next
  • Posted

    Perhaps this recent report will give you some pause and refelction of any decision you make.

    The following official statement was issued on September 15 by the American Society for Radiation Oncology (ASTRO):ASTRO ENCOURAGES PROSTATE CANCER PATIENTS TO WEIGH LONG-TERM IMPACT OF TREATMENT OPTIONS WITH THEIR DOCTORS

    In light of the findings from the Prostate Testing for Cancer and Treatment (ProtecT) trial published in the New England Journal of Medicine, the American Society for Radiation Oncology (ASTRO) would like to congratulate the authors and investigators for conceiving and completing a difficult clinical trial to randomize care for 2,664 men who volunteered to be a part of this study. Their paper emphasizes the importance of joint decision making between prostate cancer patients and their physicians when weighing treatment options for early stage disease. Findings from the ProtecT trial can help patients understand the full range of approaches to manage their disease, including the risks and benefits of active monitoring versus early treatment with radiation therapy (RT) or surgery.

    Ten-year findings from the trial indicate that for men with early stage prostate cancer, there is no difference in mortality rates following active monitoring, surgery or RT, and moreover, that cancer-specific deaths at ten years following diagnosis averaged only one percent for all men enrolled in the trial.

    Growth of the cancer outside of the prostate did vary between monitoring and treatment groups. Rates of both regional spread and distant metastases were significantly higher for men who were monitored rather than treated for their early stage disease. Progression did not vary, however, between the surgery and RT groups, although patients in the trial reported different side effects with each modality.

    “These findings underscore the essential role of dialogue in treatment selection,” said ASTRO President David C. Beyer, MD, FASTRO. “Men with prostate cancer are all different, and the relative costs and benefits associated with the multiple options to treat it can vary substantially between individuals. The best treatment decisions for prostate cancer, or any cancer, take into consideration the specifics of each individual patient’s disease, expectations and preferences. These options can be confusing, and patients should always make these decisions after consultation with a radiation oncologist and urologist”

    ASTRO, the American Urological Association (AUA) and the American Society for Clinical Oncology (ASCO) are currently developing updated guidelines for the management of clinically localized prostate cancer. The recommendations, which update a 2007 collaborative guideline issued by the societies, are scheduled for publication in mid-2017.

    The “New” Prostate Cancer InfoLink considers this statement to be entirely appropriate based on the data, and we are delighted to see that ASTRO and the American Urological Association (AUA) will be issuing a badly needed, joint update to their guidelines on the management of clinically localized prostate cancer as a consequence! As yet we have seen no formal statement from the AUA.

     

    • Posted

      Great post aksns61.

      That's the kind of info that we need on this forum!

    • Posted

      What is "early stage"?

      Is a Gleason 3+3 believed to be contained in the prostate considered "early stage"? What about a Gleason 4+5 believed to be contained in the prostate. Is that considered "early stage"?

       

    • Posted

      barney,

      My Gleason score was 4+3 =7. This score is considered intermediate. I consider

    • Posted

      Great question I have monitored mine for 12 years and they doctor said Gleason 6 was the number that treatment or in my case removal would need to be decided. My bother on the other hand is at a Gleason 3 and they after telling him to keep watching it. Hope that helps.
    • Posted

      As far as I know, in the uk, the T staging is how far or not it has spread. The Gleason score is the aggressiveness. So 3+3=6 is the lowest Gleason score. Meaning it is a slower less aggressive cancer. A 4+4 means it is more aggressive as is 5+5. But an aggressive cancer can still be contained in the prostate the same as a lower Gleason can have spread. You get a t staging in the uk this shows where it is. Got example tb1 or tb2 etc. The Gleason is nothing to do with how far it has or has not spread. It must be the same in America.
    • Posted

      barney

      Posted my reply inadvertentl, before finishing.

      A 9 Gleason score is not good in my opinion. I would not think early stage. I am not a Doctor or expert, JMO. My Gleason score 4+3 was considered intermediate cancer. However, after my Urologist sent my biopsy remains for Genetic testing the results were non aggressive, which the Gleason score of 7 was contradictory to the Genetic testing which put my cancer in the nonaggresive range. Like you said, there is no one treatment for PCA and fuction of:

      the aggressiveness of the PCa AND

      the age of the man

      That is why I chose active surivilance

      I will be reevaluated in December, so, my thoughts on which cancer is early stage has lots of determine factors. .

      I would like to read others opinion.

    • Posted

      The lowest score is 2. They really don’t start treating it till it is a 6. So you are right that 6 is the lowest score that they will start treatment. 2 to 5 they wait and see. But even then if a man is up in his 80's they may keep watching it till it gets higher.

    • Posted

      That is correct. Some don't even really consider it cancer until it hits 6. In my case, (3+3) it was low but because of the location there was more potential for it to spread and therefore prudent to take action beyond AS.

    • Posted

      In the uk a Gleason of 2 is even counted as a cancer. So 3 is the lowest.
    • Posted

      Honestly, from what I read in the. Last few months I think a 3+3 could be monitored for a while.

      of course the question is " how long is a while"

    • Posted

      ok

      so putting aside the Gleason score, would you treat a T2b with surgery or radiation or just monitor it?

    • Posted

      You make sense

      that is why I wasted no time to have my Gleason 9 robotically removed 

    • Posted

      Did you have a MRI as well? That would give you even more information eg an indication of any extraporostaric extension.

      as I am sure you know, a biopsy is a very good estimate of the PCa, but only its removal gives a definitive pathology.

      i was always worried that a biopsy can under or overestimate the PCa.

    • Posted

      Yes, I had a MRI. The PCa was not outside of the prostate With my Gleason of 7, I would be having treatment now. But, the Prolaris score in the non aggressive range, and mortality rate of 3% of not dying in 10 years was a deciding factor of active surveillance. There still remains a possibility of treatment in the future after evaluation in December. Hopefully I can continue on. Like I said before the Genetic testing at Prolaris showed a non aggressive PCa. So, you could probably say they were contradictory of each other.
    • Posted

      The best people to help you arrive at a treatment decision are the medical staff who know your condition. While outside forums are useful, we are only a voice of opinions. Cold numbers are only part of the whole equation and you can quickly bury yourself in a quagmire of statistics. Have very frank discussions with your health professionals. Meanwhile also have frank talk to your spouse, because they will be impacted by any of the treatment options and are key to your recovery.
    • Posted

      Further to Aksn's comments, when it comes to possibly undergoing treatment, find one urologist you trust and be guided by him.

    • Posted

      aksns61,

      I do appreciate your reply to my status. To clarify my treatment decisions, My medical staff was very much involved in all my treatment decisions.

    • Posted

      barney,

      Just to reinterate my treatment decision. My Urologist made the decision that I go on active surveillance, I was hesitiant at first, but Along with my family, wife and 4 daughters agreed after the rest results came back from Myriad Genetics, (Prolaris) . My family and I have decided to trust his decision. but, I am a little skeptical of trusting any one, but thats just me.

      This was the deciding factor in my treatment decision.

      The New genetic tests make it easier to identify aggressive early stage cancers. Prolaris, which tests for 46 genes, has been shown in studies to accurately predict the aggressiveness of a patient's prostate tumour in conjunction with Gleason scores and PSA tests. My tests came back in the non aggresive range.

       

    • Posted

      Tough call.

      i like you would be skeptical about AS.

      how reliable is the genetic test?

      i am not sure I would go that route with a Gleason 7 which is really the best estimate.

      only when a prostate is removed can one tell for sure the Gleason score, which may be different to 7

      what tumor stage is it?

    • Posted

      Stage 1, I am scheduled for another PSA reading in November. Another treatment decision can be made then.

      I called Myriad Laboratories (Prolaris ) and had a long discussion with a lab tech. And with my Prolaris score, he also agreed with my Urologist, that I was a candidate for AS.

      I feel like I have time to make a definite treatment decision after my next evaluation.

      Did I mention I just turned 76 years old. If I had been 15 -20 years. Younger. No doubt, I would have chose treatment, My thoughts are, if I can forgo evasive treatment for what years I have left is a no brainer. No one is promised tomorrow.

    • Posted

      Ok, so now I know you are 76. And the stage is T1.

      in your position I would do as you're doing: AS, even without the Prolaris test.

       

    • Posted

      Thanks,barney ,

      Yes the stage is T1c, meaning cancer found via a needle biopsy and biopsy initiated by abnormal PSA.

      There is TIa , TIb and T1c . Either 3 means cancer is present.

       

Report or request deletion

Thanks for your help!

We want the community to be a useful resource for our users but it is important to remember that the community are not moderated or reviewed by doctors and so you should not rely on opinions or advice given by other users in respect of any healthcare matters. Always speak to your doctor before acting and in cases of emergency seek appropriate medical assistance immediately. Use of the community is subject to our Terms of Use and Privacy Policy and steps will be taken to remove posts identified as being in breach of those terms.